Diabetic Foot Ulcers and Pressure Ulcers Market: By Disease Type (Diabetic Foot Ulcers, Pressure Ulcers), By Treatment (Wound Care Dressings, Bio-actives, Wound Care Devices), By End User (Hospitals, Clinics, Home Healthcare, Community Health Centers, Others), and Geography


Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Diabetic Foot Ulcers And Pressure Ulcers Market size was valued at 4,609.2 million in 2021 and is expected to reach 7,747.0 million by 2028, at a CAGR of 7.7% during the forecast period 2022 to 2028. Diabetic foot ulcers are the full-thickness wounds present below the ankle in diabetic patients. The risk factors for the diabetic foot ulcers include poor blood circulation, neuropathy, and insufficiently well controlled diabetes are among others. Pressure ulcers or bedsores are injuries to skin and underlying tissue, caused by the prolonged pressure on skin. Pressure ulcers are majorly affect the persons with paralysis, old age, illness, and frailty.

Global Diabetic Foot Ulcers And Pressure Ulcers Market Summary

Study Period


Base Year




Largest Market


Fastest Growing Market

Diabetic Foot Ulcers And Pressure Ulcers Market

Increase in the prevalence diabetes and neuropathic diseases such as paralysis surge the global diabetic foot ulcers and pressure ulcers market. Moreover, rise in R&D expenditure for the innovation of newer therapeutics, government initiations to control the diabetes and chronic wounds, grow in incidence of paralysis and other chronic diseases reduces the mobility, unhealthy lifestyle, and increase in geriatric population are anticipated to propel the diabetic foot ulcers and pressure ulcers market over the forecast years. However, high cost of treatment, dearth of skilled professionals in underdeveloped countries, and limited number of biologicals for the treatment are restrain the growth of global market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Global Diabetic Foot Ulcers And Pressure Ulcers Market Segmentation

disease type
  • Diabetic Foot Ulcers
  • Grade 0
  • Grade 1
  • Grade 2
  • Grade 3
  • Grade 4
  • Grade 5
  • Pressure Ulcers
  • Stage 1
  • Stage 2
  • Stage 3
  • Stage 4
treatment type
  • Wound Care Dressings
  • Film Dressings
  • Foam Dressings
  • Hydrogel Dressings
  • Hydrocolloid Dressings
  • Alginate Dressings
  • Others
  • Bio-actives
  • Growth Factors
  • Skin Substitute & Skin Grafts
  • Others
  • Wound Care Devices
  • Negative Pressure Wound Therapy (NPWT)
  • Ultrasound Therapy
  • Others
By End User
  • Hospitals
  • Clinics
  • Home Healthcare
  • Community Health Canters
  • Others

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

[urltag url='request-table-of-content']

  • Medtronic plc (Ireland)
  • Braun Melsungen AG (Germany)
  • Smith & Nephew plc (U.K.)
  • CovaTec, Inc. (U.S.)
  • Coloplast A/S (Denmark)
  • Organogenesis, Inc. (U.S.)
  • Medline Industries, Inc. (U.S.)
  • 3M Healthcare (U.S.)
  • BSN Medical GmbH (Hamburg)
  • Integra Life Sciences Corporation (U.S.)
  • Molnlycke Health Care AB (Sweden)